Michael McMorris, Jr.
Nursing Home Administrators at Timpson Ave, Durham, NC

License number
North Carolina 2661
Expiration Date
Sep 30, 2018
Category
Nursing Home Administrator
Address
Address
509 Timpson Ave, Durham, NC 27703

Professional information

Michael Jr. Photo 1

Michael Posey Jr. - Durham, NC

Work:
Bojangle's
Utility Worker/ Housekeeping
Durham Coca Cola Co. - Durham, NC
Production Filler Operator & labeler Operator
Education:
Northen High School - Durham, NC
High school diploma in English, Math
Skills:
18 yrs. driving a forklift & Warehouse experience. 1 year experience in House Keeping.


Michael Jr. Photo 2

Method Of Screening For Drug Hypersensitivity Reaction

US Patent:
7550261, Jun 23, 2009
Filed:
Aug 7, 2002
Appl. No.:
10/214023
Inventors:
Seth Hetherington - Alpharetta GA, US
Arlene R Hughes - Durham NC, US
Eric H Lai - Durham NC, US
Michael Mosteller, Jr. - Durham NC, US
Denise D Shortino - Durham NC, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 6, 435 911, 435 912, 536 243
Abstract:
Methods of assessing the risk of clinical signs of hypersensitivity reaction to nucleoside antiviral compounds, including abacavir, are described. The methods include genotyping subjects for polymorphisms in the TNFα gene, the class 1 HLA genes, or a combination of both the TNFα and HLA genes.


Michael Jr. Photo 3

Method Of Screening For Drug Hypersensitivity Reaction

US Patent:
7858319, Dec 28, 2010
Filed:
Apr 22, 2009
Appl. No.:
12/428034
Inventors:
Seth Hetherington - Alpharetta GA, US
Arlene R Hughes - Durham NC, US
Eric H Lai - Durham NC, US
Michael Mosteller, Jr. - Durham NC, US
Denise D Shortino - Durham NC, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
Methods of assessing the risk of clinical signs of hypersensitivity reaction to nucleoside antiviral compounds, including abacavir, are described. The methods include genotyping subjects for polymorphisms in the TNFα gene, the class 1 HLA genes, or a combination of both the TNFα and HLA genes.